W. Koestler

1.0k total citations
26 papers, 707 citations indexed

About

W. Koestler is a scholar working on Oncology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, W. Koestler has authored 26 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Surgery and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in W. Koestler's work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Peptidase Inhibition and Analysis (5 papers). W. Koestler is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Peptidase Inhibition and Analysis (5 papers). W. Koestler collaborates with scholars based in Austria, Germany and United States. W. Koestler's co-authors include Norbert P. Suedkamp, P. C. Strohm, Ulf Culemann, Hagen Schmal, Oliver Hauschild, Tim Pohlemann, Dirk Maier, Martin Jaeger, Philipp Niemeyer and Christopher Brooks and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Bone and Joint Surgery.

In The Last Decade

W. Koestler

25 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Koestler Austria 12 468 150 126 112 80 26 707
A.C.M. van Lindert Netherlands 11 370 0.8× 186 1.2× 179 1.4× 40 0.4× 51 0.6× 17 768
Pilar Solves Spain 18 206 0.4× 96 0.6× 83 0.7× 67 0.6× 145 1.8× 73 896
Afaf Amarti Morocco 15 326 0.7× 168 1.1× 145 1.2× 27 0.2× 83 1.0× 99 758
Noriko Asuwa Japan 15 388 0.8× 109 0.7× 61 0.5× 28 0.3× 102 1.3× 21 729
X. Tillou France 17 346 0.7× 209 1.4× 64 0.5× 71 0.6× 90 1.1× 72 861
Andrzej Prokurat Poland 12 282 0.6× 76 0.5× 58 0.5× 23 0.2× 39 0.5× 30 468
Alessandro Del Gobbo Italy 12 143 0.3× 109 0.7× 84 0.7× 14 0.1× 103 1.3× 60 421
Els van Beelen Netherlands 15 92 0.2× 94 0.6× 95 0.8× 136 1.2× 89 1.1× 26 804
Hidehiro Matsuura Japan 16 637 1.4× 359 2.4× 49 0.4× 24 0.2× 53 0.7× 36 1.0k
H Sugao Japan 13 193 0.4× 98 0.7× 32 0.3× 24 0.2× 94 1.2× 56 526

Countries citing papers authored by W. Koestler

Since Specialization
Citations

This map shows the geographic impact of W. Koestler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Koestler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Koestler more than expected).

Fields of papers citing papers by W. Koestler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Koestler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Koestler. The network helps show where W. Koestler may publish in the future.

Co-authorship network of co-authors of W. Koestler

This figure shows the co-authorship network connecting the top 25 collaborators of W. Koestler. A scholar is included among the top collaborators of W. Koestler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Koestler. W. Koestler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Day, Elizabeth, Kim Leitzel, Suhail M. Ali, et al.. (2020). Abstract P4-10-25: Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer. Cancer Research. 80(4_Supplement). P4–10. 7 indexed citations
2.
Lipton, Allan, Kim Leitzel, Suhail M. Ali, et al.. (2018). High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts. International Journal of Cancer. 143(11). 3027–3034. 45 indexed citations
3.
Höetzenecker, Konrad, Wolfgang Lamm, W. Koestler, et al.. (2014). Pulmonary metastasectomy for soft tissue sarcoma – Report from a dual institution experience at the Medical University of Vienna. European Journal of Cancer. 50(13). 2289–2297. 26 indexed citations
4.
Niemeyer, Philipp, et al.. (2010). Probleme und Komplikationen chirurgischer Verfahren zur Behandlung vollschichtiger Knorpeldefekte am Kniegelenk. Zeitschrift für Orthopädie und Unfallchirurgie. 149(1). 45–51. 21 indexed citations
5.
Ogon, Peter, Norbert P. Suedkamp, Martin Jaeger, et al.. (2009). Prognostic factors in nonoperative therapy for chronic symptomatic calcific tendinitis of the shoulder. Arthritis & Rheumatism. 60(10). 2978–2984. 85 indexed citations
6.
Lipton, Allan, Kim Leitzel, W. Koestler, et al.. (2009). HER2 protein expression predicts response to trastuzumab in FISH-positive patients.. Cancer Research. 69(2_Supplement). 32–32. 1 indexed citations
7.
Goodman, Laurie J., Ali Mukherjee, Jeff Sperinde, et al.. (2009). Quantitative measurement of HER3 total protein (H3T) and association with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. Journal of Clinical Oncology. 27(15_suppl). 1021–1021. 2 indexed citations
8.
Niemeyer, Philipp, W. Koestler, Peter Kreuz, et al.. (2008). Two‐Year Results of Open‐Wedge High Tibial Osteotomy With Fixation by Medial Plate Fixator for Medial Compartment Arthritis With Varus Malalignment of the Knee. Arthroscopy The Journal of Arthroscopic and Related Surgery. 24(7). 796–804. 115 indexed citations
9.
Hauschild, Oliver, P. C. Strohm, Ulf Culemann, et al.. (2008). Mortality in Patients With Pelvic Fractures: Results From the German Pelvic Injury Register. The Journal of Trauma: Injury, Infection, and Critical Care. 64(2). 449–455. 197 indexed citations
10.
Schmal, Hagen, Bernd Gutmann, Norbert P. Südkamp, et al.. (2008). Klinische Evaluation evidenzbasierter Kriterien für die CT-Diagnostik bei der Behandlung der Commotio cerebri. Zeitschrift für Orthopädie und Unfallchirurgie. 146(5). 595–601. 2 indexed citations
11.
Koestler, W., et al.. (2008). A feasibility study of computer-assisted bone graft implantation for tissue-engineered replacement of the human ankle joint. Computer Aided Surgery. 13(4). 207–217. 4 indexed citations
12.
Maier, Dirk, Martin Jaeger, Norbert P. Suedkamp, & W. Koestler. (2007). Stabilization of the Long Head of the Biceps Tendon in the Context of Early Repair of Traumatic Subscapularis Tendon Tears. Journal of Bone and Joint Surgery. 89(8). 1763–1769. 35 indexed citations
13.
Maier, Dirk, Martin Jaeger, Norbert P. Suedkamp, & W. Koestler. (2007). Stabilization of the Long Head of the Biceps Tendon in the Context of Early Repair of Traumatic Subscapularis Tendon Tears. Journal of Bone and Joint Surgery. 89(8). 1763–1769. 7 indexed citations
14.
Bartsch, Rupert, Catharina Wenzel, Ursula Pluschnig, et al.. (2006). Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational study. BMC Cancer. 6(1). 63–63. 41 indexed citations
15.
Gschwantler‐Kaulich, Daphne, Gernot Hudelist, W. Koestler, et al.. (2005). EGFR activity in HER-2 over-expressing metastatic breast cancer: evidence for simultaneous phosphorylation of Her-2/neu and EGFR. Oncology Reports. 14(2). 305–11. 13 indexed citations
16.
Hudelist, Gernot, W. Koestler, Johannes Attems, et al.. (2004). Active Her-2/neu signal transduction in breast cancer –relevance of a ligand-independent activation mechanism and impact on the efficacy of trastuzumab-based treatment. Journal of Clinical Oncology. 22(14_suppl). 649–649. 3 indexed citations
17.
Koestler, W., Peter Horak, Thomas W. Grunt, et al.. (2003). Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines. European Journal of Cancer. 39(9). 1318–1329. 32 indexed citations
18.
Brodowicz, Thomas, Daniela Kandioler, Christian Ludwig, et al.. (2001). Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status. British Journal of Cancer. 85(11). 1764–1770. 19 indexed citations
19.
Koestler, W., T. Brodowicz, Michael Hejna, et al.. (2001). Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial. European Journal of Cancer. 37. S85–S85. 1 indexed citations
20.
Brodowicz, Thomas, W. Koestler, Sandra Tomek, et al.. (2000). Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer. Anti-Cancer Drugs. 11(3). 149–153. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026